Somewhat Favorable Media Coverage Somewhat Unlikely to Impact Danaher (DHR) Share Price

Media coverage about Danaher (NYSE:DHR) has been trending somewhat positive on Wednesday, Accern Sentiment Analysis reports. The research firm rates the sentiment of media coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Danaher earned a media sentiment score of 0.17 on Accern’s scale. Accern also gave news headlines about the conglomerate an impact score of 46.4918112297217 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

Here are some of the headlines that may have effected Accern’s analysis:

Shares of Danaher (NYSE DHR) traded down $0.21 during mid-day trading on Wednesday, hitting $92.53. 2,038,382 shares of the stock were exchanged, compared to its average volume of 2,630,318. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.00 and a current ratio of 1.43. The company has a market cap of $64,566.07, a PE ratio of 23.86, a price-to-earnings-growth ratio of 2.21 and a beta of 1.02. Danaher has a 12 month low of $76.27 and a 12 month high of $94.82.

Danaher (NYSE:DHR) last issued its earnings results on Thursday, October 19th. The conglomerate reported $1.00 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.95 by $0.05. The company had revenue of $4.53 billion for the quarter, compared to analysts’ expectations of $4.47 billion. Danaher had a net margin of 13.36% and a return on equity of 11.29%. Danaher’s quarterly revenue was up 9.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.87 EPS. research analysts anticipate that Danaher will post 3.99 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, January 26th. Stockholders of record on Friday, December 29th will be issued a $0.14 dividend. The ex-dividend date is Thursday, December 28th. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.61%. Danaher’s payout ratio is 16.52%.

DHR has been the subject of a number of research analyst reports. Goldman Sachs Group reaffirmed a “neutral” rating and issued a $83.00 target price on shares of Danaher in a research note on Tuesday, September 26th. Credit Suisse Group increased their price objective on shares of Danaher from $93.00 to $96.00 and gave the stock an “outperform” rating in a research note on Friday, October 20th. J P Morgan Chase & Co restated an “overweight” rating and set a $95.00 price objective on shares of Danaher in a research note on Friday, September 8th. Robert W. Baird increased their price objective on shares of Danaher from $87.00 to $97.00 and gave the stock an “outperform” rating in a research note on Friday, October 20th. Finally, Morgan Stanley increased their price objective on shares of Danaher from $95.00 to $98.00 and gave the stock an “overweight” rating in a research note on Friday, October 20th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $93.31.

In other news, Director Donald J. Ehrlich sold 10,578 shares of the company’s stock in a transaction dated Tuesday, October 24th. The shares were sold at an average price of $90.82, for a total value of $960,693.96. Following the sale, the director now directly owns 104,621 shares of the company’s stock, valued at approximately $9,501,679.22. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CEO Thomas Patrick Joyce, Jr. sold 125,989 shares of the company’s stock in a transaction dated Wednesday, November 1st. The shares were sold at an average price of $92.64, for a total transaction of $11,671,620.96. Following the completion of the sale, the chief executive officer now directly owns 271,737 shares in the company, valued at $25,173,715.68. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 273,810 shares of company stock worth $25,218,813. 12.20% of the stock is owned by insiders.

ILLEGAL ACTIVITY WARNING: “Somewhat Favorable Media Coverage Somewhat Unlikely to Impact Danaher (DHR) Share Price” was originally posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this news story on another site, it was illegally copied and reposted in violation of United States and international copyright and trademark laws. The original version of this news story can be viewed at https://ledgergazette.com/2017/12/06/somewhat-favorable-media-coverage-somewhat-unlikely-to-impact-danaher-dhr-share-price.html.

About Danaher

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Insider Buying and Selling by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply